TrialeLife2024

Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial.

Joanna C Porter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.